Your browser doesn't support javascript.
SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster.
Wang, Qian; Bowen, Anthony; Tam, Anthony R; Valdez, Riccardo; Stoneman, Emily; Mellis, Ian A; Gordon, Aubree; Liu, Lihong; Ho, David D.
  • Wang Q; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.
  • Bowen A; Division of Infectious Diseases, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.
  • Tam AR; Division of Infectious Diseases, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Valdez R; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Stoneman E; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Mellis IA; Department of Pathology and Cell Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.
  • Gordon A; Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.
  • Liu L; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.
  • Ho DD; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA. Electronic address: dh2994@cumc.columbia.edu.
Lancet Infect Dis ; 23(5): 527-528, 2023 05.
Article in English | MEDLINE | ID: covidwho-2286103

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2023 Document Type: Article Affiliation country: S1473-3099(23)00181-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2023 Document Type: Article Affiliation country: S1473-3099(23)00181-0